Literature DB >> 23873275

Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome.

Ramzy H Rimawi1, Mark A Mazer, Dawd S Siraj, Mike Gooch, Paul P Cook.   

Abstract

OBJECTIVE: Antimicrobial stewardship programs have been shown to help reduce the use of unnecessary antimicrobial agents in the hospital setting. To date, there has been very little data focusing on high-use areas, such as the medical ICU. A prospective intervention was done to assess guideline compliance, antimicrobial expenditure, and healthcare cost when an infectious disease fellow interacts regularly with the medical ICU team.
DESIGN: A 3-month retrospective chart review was followed by a 3-month prospective intervention the following year. Two hundred forty-six total charts were reviewed to assess generally accepted guideline compliance, demographics, and microbiologic results.
SETTING: Twenty-four-bed medical ICU at an 861-bed tertiary care, university teaching hospital in North Carolina.
SUBJECTS: Patients receiving antibiotics in the medical ICU. INTERVENTION: During the intervention period, the infectious disease fellow reviewed the charts, including physician notes and microbiology data, and discussed antimicrobial use with the medical ICU team.
MEASUREMENTS AND MAIN RESULTS: Antimicrobial use, treatment duration, Acute Physiology and Chronic Health Evaluation II scores, length of stay, mechanical ventilation days, and mortality rates were compared during the two periods. RESULTS: No baseline statistically significant differences in the two groups were noted (i.e., age, gender, race, or Acute Physiology and Chronic Healthcare Evaluation II scores). Indications for antibiotics included healthcare-associated (53%) and community-acquired pneumonias (17%). Significant reductions were seen in extended-spectrum penicillins (p=0.0080), carbapenems (p=0.0013), vancomycin (p=0.0040), and metronidazole (p=0.0004) following the intervention. Antimicrobial modification led to an increase in narrow-spectrum penicillins (p=0.0322). The intervention group had a significantly lower rate of treatments that did not correspond to guidelines (p<0.0001). There was a reduction in mechanical ventilation days (p=0.0053), length of stay (p=0.0188), and hospital mortality (p=0.0367). The annual calculated healthcare savings was $89,944 in early antibiotic cessation alone.
CONCLUSION: Active communication with an infectious disease practitioner can significantly reduce medical ICU antibiotic overuse by earlier modification or cessation of antibiotics without increasing mortality. This in turn can reduce healthcare costs, foster prodigious education, and strengthen relations between the subspecialties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873275     DOI: 10.1097/CCM.0b013e31828e9863

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

Review 1.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

2.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

Review 3.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

4.  [Update on intensive care medicine. Most important publications from 2012-2014].

Authors:  J Knapp; M Bernhard; S Hofer; E Popp; M A Weigand
Journal:  Anaesthesist       Date:  2014-05       Impact factor: 1.041

5.  Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?

Authors:  Kaushal B Shah; Ramzy H Rimawi; Mark A Mazer; Paul P Cook
Journal:  Infection       Date:  2017-07-19       Impact factor: 3.553

6.  Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study.

Authors:  Maher R Khdour; Hussein O Hallak; Mamoon A Aldeyab; Mowaffaq A Nasif; Aliaa M Khalili; Ahamad A Dallashi; Mohammad B Khofash; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2018-01-23       Impact factor: 4.335

7.  How Can We Optimize Antibiotic Use in the PICU?

Authors:  Kathleen Chiotos; Jeffrey S Gerber; Adam S Himebauch
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

8.  A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care.

Authors:  Francisco Álvarez-Lerma; Santiago Grau; Daniel Echeverría-Esnal; Montserrat Martínez-Alonso; María Pilar Gracia-Arnillas; Juan Pablo Horcajada; Juan Ramón Masclans
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

9.  Agreement on the prescription of antimicrobial drugs.

Authors:  Eduardo Casaroto; Alexandre R Marra; Thiago Zinsly Sampaio Camargo; Ana Rita Araújo de Souza; Carlos Eduardo Saldanha de Almeida; Elizia Piassi Pedroti; Elivane da Silva Victor; Oscar Fernando Pavão dos Santos; Michael B Edmond; Alexandre Holthausen Campos
Journal:  BMC Infect Dis       Date:  2015-06-30       Impact factor: 3.090

10.  Reversing the Trend of Antimicrobial Resistance in ICU: Role of Antimicrobial and Diagnostic Stewardship.

Authors:  Jyotsna Agarwal; Vikramjeet Singh; Anupam Das; Soumya S Nath; Rajeev Kumar; Manodeep Sen
Journal:  Indian J Crit Care Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.